Despite rising prevalence of heart disease in China, primary preventive treatment rates remain low American College of Physicians
M18-3301
URLs go live when the embargo lifts
About one in 10 middle-aged adults in China are at high risk for cardiovascular disease (CVD), yet use of risk reduction therapies is strikingly low. Findings from a Chinese national screening project are published in Annals of Internal Medicine .
Despite rising prevalence of heart disease in China, primary preventive treatment rates remain low
Disclosure: This site contains some affiliate links. We might receive a small commission at no additional cost to you.